Home > Insider Trading > Filing (0000895345-22-000790)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1759655	Privia Health Group Inc.	PRVA	Services-Health Services (8000)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1859499	Daniel Jeffrey Bernstein	200 West Street New York NY 10282		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-11-21	3,186,888	$22.56	24,826,071	No	4	S	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnotes

Footnotes

The Reporting Person is a managing director of Goldman Sachs & Co. LLC ("Goldman Sachs"). Goldman Sachs is a subsidiary of The Goldman Sachs Group, Inc. ("GS Group"). The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any.
Pursuant to an underwriting agreement, dated November 16, 2022 (the "Underwriting Agreement"), the GS Funds (as defined below) offered and sold an aggregate 3,186,888 shares of Common Stock as set forth in the final prospectus filed by the Issuer on November 18, 2022, which offering was consummated on November 21, 2022 (the "Offering"). The amount above represents the $23.50 public offering price per share of Common Stock in the Offering less the underwriting discount of $0.94 per share of Common Stock.
As of November 21, 2022, as a result of the Offering, GS Group and Goldman Sachs may be deemed to beneficially own indirectly 24,826,071 shares of Common Stock by reason of Common Stock held by certain investment entities (the "GS Funds") of which Goldman Sachs and GS Group are the general partner, managing limited partner, managing general partner, managing partner, managing member or member.